Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smoke-Free homes boost quit rates in Low-Income smokers

NCT ID NCT04547686

Disease control Sponsor: Emory University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 19, 2026 · Updated 2 times

Summary

This study tested a program to help low-income smokers quit by making their homes and cars smoke-free. 918 adults received mailings and coaching calls to create smoking bans. The goal was to see if this approach led to more people quitting smoking for good.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

916 people

The number who actually took part.

Started

Nov 2020

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18 years of age and older * referred by primary care physician or provider of a participating Federally Qualified Health Center (FQHC) in Georgia * have smoked at least one cigarette in the past 30 days * has ability to speak and understand English * be the only patient per household to be enrolled in the study * not currently be enrolled in a cessation program Exclusion Criteria: * non-smoker * unable to speak or understand English * under 18 years of age * have another family or household member participating in the research * vulnerable special populations will not be enrolled, including: * adults unable to consent * pregnant women * prisoners * cognitively impaired or Individuals with Impaired Decision-Making Capacity * not able to clearly understand English * community participation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cessation, smoking are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Smoking Cessation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cessation, smoking

Contacts and locations

Locations

  • Rollins School of Public Health, Emory University

    Atlanta, Georgia, 30322, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.